Hisashi Wakita

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

Jun Imagawa, Hideo Tanaka, Masaya Okada et al. · The Lancet Haematology · 2015 · 300 citations

Medicine, Hematology, Oncology +4

Direct estimation of the vocal tract shape by inverse filtering of acoustic speech waveforms

Hisashi Wakita · IEEE Transactions on Audio and Electroacoustics · 1973 · 259 citations

Language Studies, Linguistics, Acoustics +16

Normalization of vowels by vocal-tract length and its application to vowel identification

Hisashi Wakita · IEEE Transactions on Acoustics Speech and Signal Processing · 1977 · 196 citations

Language Studies, Linguistics, Acoustics +15

Extranodal natural killer/T‐cell lymphoma, nasal type

Koichi Isobe, Takashi Uno, Jun‐ichi Tamaru et al. · Cancer · 2005 · 141 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 117 citations · Full text

Medicine, Oncology, Pharmacology +9